Skip to main content

Table 1 The physicochemical properties of newly synthesized derivatives (121)

From: Synthesis, SAR and in vitro therapeutic potentials of thiazolidine-2,4-diones

Compound

M. formula

M. weight

m.pt. (°C)

Rf value

% yield

1

C10H6N2O4S

250.23

178–180

0.73

98.00

2

C10H6ClNO2S

239.68

150–153

0.51

98.17

3

C10H5Cl2NO2S

274.12

167–170

0.58

95.57

4

C10H6N2O4S

250.23

128–130

0.66

98.73

5

C10H7NO3S

221.23

160–165

0.65

97.56

6

C12H12N2O2S

248.3

147–150

0.63

79.92

7

C10H6N2O4S

250.23

110–113

0.72

95.73

8

C14H16N2O2S

276.35

158–160

0.61

67.93

9

C10H6BrNO2S

284.13

150–152

0.63

96.52

10

C13H13NO5S

295.31

210–213

0.61

98.18

11

C12H11NO4S

265.29

158–160

0.72

94.33

12

C11H9NO3S

235.26

187–190

0.71

98.00

13

C10H6ClNO2S

239.68

133–135

0.66

78.89

14

C10H6ClNO2S

239.65

137–140

0.76

88.91

15

C11H9NO3S

235.26

147–150

0.63

77.89

16

C11H9NO3S

235.26

217–220

0.41

95.78

17

C10H7NO3S

221.23

227–230

0.46

89.45

18

C11H9NO4S

251.26

240–243

0.33

97.97

19

C12H11NO4S

265.29

220–223

0.57

81.47

20

C12H9NO2S

231.27

130–133

0.43

90.20

21

C11H7NO3S

233.24

147–150

0.91

96.78

  1. TLC mobile phase-n-hexane:ethylacetate